Risk factors and outcomes of bloodstream infections with metallo-β-lactamase-producing Acinetobacter

Scandinavian Journal of Infectious Diseases

Volumn 40, Issue 3, 2008, Pages 234-240

  Kim, Yeon A ^a   Choi, Jun Yong ^a   Kim, Chang Ki ^a   Kim, Chang Oh ^a   Kim, Myung Soo ^a   Choi, Suk Hoon ^a   Chin, Bum Sik ^a   Han, Sang Hoon ^a   Lee, Han Sung ^a   Choi, Hee Kyoung ^a   Jeoung, Su Jin ^a   Song, Young Goo ^a   Yum, Jong Hwa ^a   Yong, Dongeun ^a   Lee, Kyungwon ^a   Kim, June Myung ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CARBAPENEM; CEPHALOSPORIN DERIVATIVE; IMIPENEM; METALLO BETA LACTAMASE; PENICILLIN G; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACINETOBACTER; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOOD CULTURE; CASE CONTROL STUDY; CLINICAL FEATURE; CONTROLLED STUDY; DRUG USE; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEUTROPENIA; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; RISK FACTOR; TEACHING HOSPITAL;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMASES; CARBAPENEMS; CASE-CONTROL STUDIES; CEPHALOSPORINS; DNA FINGERPRINTING; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUTROPENIA; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 39349101559     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540701633004     Document Type: Article

References (27)

1. Jones, RN, Kirby, JT, Beach, ML, Biedenbach, DJ and Pfaller, MA. (2002) Geographic variations in activity of broad-spectrum β-lactams against Pseudomonas aeruginosa: Summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000). Diagn Microbiol Infect Dis, 43, pp. 239-243.
2. Pfaller, MA and Jones, RN. (2000) MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from the Americas: resistance implications in the treatment of serious infections. MYSTIC Study Group (Americas). J Antimicrob Chemother, 46, pp. 25-37.
3. Arakawa, Y., Murakami, M., Suzuki, K., Ito, H., Wacharotayankun, R. and Ohsuka, S. (1995) A novel integron-like element carrying the metallo-β-lactamase gene blaIMP. Antimicrob Agents Chemother, 39, pp. 1612-1615.
4. Yan, JJ, Hsueh, PR, Ko, WC, Luh, KT, Tsai, SH and Wu, HM (2001) Metallo-β-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob Agents Chemother, 45, pp. 2224-2228.
5. Lauretti, L., Riccio, ML, Mazzariol, A., Cornaglia, G., Amicosante, G. and Fontana, R. (1999) Cloning and characterization of blaVIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother, 43, pp. 1584-1590.
6. Lee, K., Lim, JB, Yum, JH, Yong, D., Chong, Y. and Kim, JM (2002) bla(VIM-2) cassette-containing novel integrons in metallo-β-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital. Antimicrob Agents Chemother, 46, pp. 1053-1058.
7. Marra, AR, Pereira, CA, Gales, AC, Menezes, LC, Cal, RG and de Souza, JM (2006) Bloodstream infections with metallo-β-lactamase-producing Pseudomonas aeruginosa: Epidemiology, microbiology, and clinical outcomes. Antimicrob Agents Chemother, 50, pp. 388-390.
8. Richet, HM, Mohammed, J., McDonald, LC and Jarvis, WR. (2001) Building communication networks: International network for the study and prevention of emerging antimicrobial resistance. Emerg Infect Dis, 7, pp. 319-322.
9. Bush, K. (2001) New β-lactamases in Gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin Infect Dis, 32, pp. 1085-1089.
10. Jacoby, GA and Munoz-Price, LS. (2005) The new β-lactamases. N Engl J Med, 352, pp. 380-391.
11. Nordmann, P. and Poirel, L. (2002) Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect, 8, pp. 321-331.
12. Clinical and Laboratory Standards Institute (CLSI) (2007) Performance standards for antimicrobial disk susceptibility testing: 16th informational supplement.
13. Lee, K., Chong, Y., Shin, HB, Kim, YA, Yong, D. and Yum, JH. (2001) Modified Hodge and EDTA-disk synergy tests to screen metallo-β-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect, 7, pp. 88-91.
14. Lee, K., Yum, JH, Yong, D., Lee, HM, Kim, HD and Docquier, JD (2005) Novel acquired metallo-β-lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother, 49, pp. 4485-4491.
15. Tenover, FC, Arbeit, RD, Goering, RV, Mickelsen, PA, Murray, BE and Persing, DH (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing. J Clin Microbiol, 33, pp. 2233-2239.
16. Garner, JS, Jarvis, WR, Emori, TG, Horan, TC and Hughes, JM. (1988) CDC definitions for nosocomial infections, 1998. Am J Infect Control, 16, pp. 128-140.
17. Castanheira, M., Toleman, MA, Jones, RN, Schmidt, FJ and Walsh, TR. (2004) Molecular characterization of a β-lactamase gene, blaGIM-1, encoding a new subclass of metallo-β-lactamase. Antimicrob Agents Chemother, 48, pp. 4654-4661.
18. Jones, RN, Biedenbach, DJ, Sader, HS, Fritsche, TR, Toleman, MA and Walsh, TR. (2005) Emerging epidemic of metallo-β-lactamase-mediated resistances. Diagn Microbiol Infect Dis, 51, pp. 77-84.
19. Walsh, TR, Toleman, MA, Hryniewicz, W., Bennett, PM and Jones, RN. (2003) Evolution of an integron carrying blaVIM-2 in Eastern Europe: report from the SENTRY Antimicrobial Surveillance Program. J Antimicrob Chemother, 52, pp. 116-119.
20. Watanabe, M., Iyobe, S., Inoue, M. and Mitsuhashi, S. (1991) Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother, 35, pp. 147-151.
21. Poirel, L., Naas, T., Nicolas, D., Collet, L., Bellais, S. and Cavallo, JD (2000) Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother, 44, pp. 891-897.
22. Lee, SO, Kim, NJ, Choi, SH, Kim, T Hyong, Chung, JW and Woo, JH (2004) Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: A case-control study. Antimicrob Agents Chemother, 48, pp. 224-228.
23. Cisneros, JM, Rodriguez-Bano, J., Fernandez-Cuenca, F., Ribera, A., Vila, J. and Pascual, A. (2005) Risk factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: A nationwide study. Clin Microbiol Infect, 11, pp. 874-879.
24. Baran, G., Erbay, A., Bodur, H., Onguru, P., Akinci, E. and Balaban, N. (2008) Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections. Int J Infect Dis, 12, pp. 16-21.
25. Katragkou, A., Kotsiou, M., Antachopoulos, C., Benos, A., Sofianou, D. and Tamiolaki, M. (2006) Acquisition of imipenem-resistant Acinetobacter baumannii in a pediatric intensive care unit: A case-control study. Intensive Care Med, 32, pp. 1384-1391.
26. Hirakata, Y., Yamaguchi, T., Nakano, M., Izumikawa, K., Mine, M. and Aoki, S. (2003) Clinical and bacteriological characteristics of IMP-type metallo-β-lactamase-producing Pseudomonas aeruginosa. Clin Infect Dis, 37, pp. 26-32.
27. Zavascki, AP, Barth, AL, Gaspareto, PB, Goncalves, AL, Moro, AL and Fernandes, JF (2006) Risk factors for nosocomial infections due to Pseudomonas aeruginosa producing metallo-β-lactamase in 2 tertiary-care teaching hospitals. J Antimicrob Chemother, 58, pp. 882-885.